Iomeron (Iomeprol)

Iomeprol contains iodine atoms that absorb X‑ray photons strongly. When injected, the iodine raises the radiodensity of blood vessels and tissues, creating a clear contrast between enhanced and non‑enhanced areas. This differential attenuation allows imaging systems to produce detailed pictures of internal structures.

The dose of Iomeron is individualized by the prescribing physician based on the specific imaging study, patient weight, renal function, and clinical context. Healthcare providers calculate the appropriate volume to achieve optimal contrast enhancement while minimizing risk.

The safety of Iomeron in pregnancy and lactation has not been definitively established. It should be used only when clearly necessary, after careful consideration of potential benefits versus risks, and in consultation with the treating obstetrician or neonatologist.

To order Iomeron, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image quality while reducing the incidence of discomfort and adverse reactions, making it a preferred choice for many CT and angiographic procedures.

Iomeron should be stored at ambient temperature, protected from direct sunlight, moisture, and extreme temperatures. Keep the vial in its original packaging until use, and avoid shaking the solution. Follow local regulations for handling injectable pharmaceuticals.

Iomeron is administered by a qualified healthcare professional via intra‑arterial, intra‑articular, or intravenous injection, depending on the imaging study. The injection is usually performed using a power injector or manual bolus, with the rate and volume determined by the imaging protocol.

The most serious risks include severe allergic reactions (anaphylaxis), acute renal impairment, and cardiovascular events such as hypotension or arrhythmias. Patients with known iodine allergy, compromised kidney function, or unstable cardiac status require careful assessment and monitoring before administration.

Iomeron should be avoided in patients with a documented severe hypersensitivity to iodinated contrast media, uncontrolled hyperthyroidism, or those who are pregnant or breastfeeding unless the diagnostic benefit outweighs potential risks. Clinicians should also exercise caution in patients with severe renal insufficiency.